semaglutide 2ml vial Flex-Dose 2 mL Injectable 2.5 mg/mL Semaglutide Flex-Dose 2 mL Injectable

we conducted this emulated target trial to evaluate the risk of developing incident PsA in T2DM patients treated with SGLT2i, GLP-1 RA, and DPP-4i.

Combining St

New study published this week in JAMA Network Open (Tatum et al) looked at GLP-1 medications in patients with breast cancer and their impact on overall survival (death from any cause) and...

GLP-1 []

Purpose of Review: This article summarizes the medical management of obesity with an emphasis on incretin-based therapeutics that target the neuro-hormonal basis of obesity.Recent Findings: Medications that mimic the effect of incretins, a group of peptide hormones released in response to nutrient intake that regulate appetite, result in potent and durable weight loss

Our functional and structural data suggest that receptor conformational dynamics associated with flexibility of the peptide N-terminal activation domain may be a key determinant of agonist efficacy